List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 707 studies with search of: "Thrombosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
2 Recruiting Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto,BAY59-7939)
3 Recruiting Rosuvastatin for Preventing Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous;   Thrombosis;   Prevention
Interventions: Drug: Rosuvastatin 20mg/d for 14days;   Drug: enoxaparin only
4 Completed Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
Conditions: Thrombosis;   Thromboembolism;   Venous Thrombosis
Intervention: Drug: Tinzaparin sodium
5 Active, not recruiting Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Deep-Vein Thrombosis Without Symptomatic Pulmonary Embolism: Einstein-DVT Evaluation
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin followed by VKA
6 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis (ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
7 Recruiting Study in an Ex-vivo Thrombosis Model With Human Umbilical Vein Endothelial Cells (HUVEC)-Perfusion
Conditions: Thrombosis;   Thrombus Formation;   Thrombus Stability
Intervention:
8 Terminated Anticoagulation Post Laparoscopic Splenectomy
Conditions: Portal Vein Thrombosis;   Splenic Vein Thrombosis
Intervention: Drug: Enoxaparin
9 Not yet recruiting Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism;   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
10 Recruiting Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
11 Completed 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism;   Deep Vein Thrombosis With Pulmonary Embolism
Interventions: Drug: Duration of anticoagulation;   Drug: Warfarin duration
12 Completed Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
Conditions: Thrombosis;   Thromboembolism;   Venous Thrombosis
Intervention: Drug: Tinzaparin sodium
13 Completed Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: warfarin accordingly INR value
14 Completed Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: Warfarin
15 Active, not recruiting Treatment of Upper Extremity Deep-Vein Thrombosis
Condition: Deep-Vein Thrombosis
Intervention: Drug: Dalteparin sodium injection
16 Recruiting Usefulness of Anticoagulant Treatment in First Isolated Symptomatic Calf Vein Thrombosis
Condition: Venous Thrombosis
Interventions: Drug: Nadroparine;   Drug: placebo
17 Completed Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
Conditions: Thrombosis;   Venous Thrombosis;   Catheter Occlusion
Intervention: Drug: Alfimeprase
18 Enrolling by invitation Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis
Condition: Deep Vein Thrombosis
Intervention: Device: OmniWave Endovascular System
19 Not yet recruiting Usefulness of Anticoagulant Treatment in Isolated Symptomatic Calf Vein Thrombosis.
Condition: Calf Vein Thrombosis
Intervention: Drug: Nadroparin versus Placebo (sterilized NaCL 0.9%)
20 Completed VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
Conditions: Deep-Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: 5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services